|
⚲
|
| Keyboard |
| Philippe Chambon | |
|---|---|
| Firm | |
| Address | 2 Park Avenue Suite 1500 New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Truveris Inc | 021-259046 | Director | 2.5 M of 10.0 M |
||
| New Leaf Growth Fund I LP | 021-257743 | Executive Officer | 20.0 M of 20.0 M |
||
| Vaxinnate Corp | 021-248311 | Director | 3.2 M of 4.3 M |
||
| Truveris Inc | 021-219918 | Director | 12.7 M of 12.7 M |
||
| QPID Inc | 021-217538 | Director | 12.3 M of 12.3 M |
||
| Truveris Inc | 021-175574 | Director | 10.0 M | ||
| Biorelix Inc | 021-174840 | Director | 2.6 M of 2.6 M |
||
| Biorelix Inc | 021-165342 | Director | 3.6 M of 5.3 M |
||
| Biorelix Inc | 021-152365 | Director | 2.4 M of 4.8 M |
||
| Vaxinnate Corp | 021-43952 | Director | 24.8 M of 25.0 M |
||
| Artisan Pharma Inc | 021-93905 | Director | 22.2 M of 22.2 M |
||
| New Leaf Venture Partners LLC | |||||
| New Leaf Biopharma Opportunities I LP | 021-229361 | Executive Officer | of 200.0 M |
10.0 M | |
| New Leaf Ventures III LP | 021-229360 | Executive Officer | of 375.0 M |
62.4 M | |